Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
- 1 August 2008
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 165 (8), 1040-1047
- https://doi.org/10.1176/appi.ajp.2008.07071135
Abstract
Objective: Nicotinic acetylcholine receptors are possible therapeutic targets for schizophrenia, as shown by neurobiological and molecular evidence for deficiencies in expression of α 7 -nicotinic ...Keywords
This publication has 37 references indexed in Scilit:
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and ValidityAmerican Journal of Psychiatry, 2008
- The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and StandardizationAmerican Journal of Psychiatry, 2008
- Galantamine for the Treatment of Cognitive Impairments in People With SchizophreniaAmerican Journal of Psychiatry, 2008
- Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode SchizophreniaArchives of General Psychiatry, 2007
- The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric ControlsNeuropsychopharmacology, 2007
- Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanismPsychopharmacology, 2003
- Nicotine and Behavioral Markers of Risk for Schizophrenia A Double-Blind, Placebo-Controlled, Cross-Over StudyNeuropsychopharmacology, 2002
- Association of Promoter Variants in the α7 Nicotinic Acetylcholine Receptor Subunit Gene With an Inhibitory Deficit Found in SchizophreniaArchives of General Psychiatry, 2002
- Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male VolunteersNeuropsychopharmacology, 2002
- Repeatable Battery for the Assessment of Neuropsychological Status as a Screening Test in Schizophrenia, I: Sensitivity, Reliability, and ValidityAmerican Journal of Psychiatry, 1999